Structured evidence table for Berberine Insulin Resistance Meta-Analysis, generated from 3 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Berberine Insulin Resistance Meta-Analysis | Probiotics alone also reduced FPG (approximately -0.80 mmol·L ⁻ ¹) and HbA1c (approximately -0.21%) compared with placebo. | 1 | Shadin M (2026) | Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study. |
| Berberine Insulin Resistance Meta-Analysis | Background Type 2 diabetes mellitus is characterized by impaired regulation of blood glucose. | 1 | Shadin M (2026) | Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study. |
| Berberine Insulin Resistance Meta-Analysis | Probiotics, synbiotics, and berberine (BBR) have been proposed as adjunctive interventions, but their overall effectiveness remains uncertain. | 1 | Shadin M (2026) | Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study. |
| Berberine Insulin Resistance Meta-Analysis | This review was based on a narrative literature search designed to identify experimental, clinical, and translational evidence linking natural products with gut barrier integrity, gut microbiota, low-grade inflammation, and metabolic endotoxemia. | 3 | Šantić Roko (2026) | Natural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives |
| Berberine Insulin Resistance Meta-Analysis | Because this article is a narrative review rather than a systematic review, formal risk-of-bias assessment and quantitative evidence synthesis were not performed. | 3 | Šantić Roko (2026) | Natural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives |
| Berberine Insulin Resistance Meta-Analysis | Over the past two decades, accumulating evidence has repositioned the gastrointestinal tract from a passive absorptive organ to an immunologically active barrier whose functional state directly influences systemic inflammatory tone and metabolic homeostasis []. | 3 | Šantić Roko (2026) | Natural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives |
| Berberine Insulin Resistance Meta-Analysis | Reference lists of relevant reviews and primary studies were additionally screened to identify articles not captured by database searches. | 3 | Šantić Roko (2026) | Natural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives |
| Berberine Insulin Resistance Meta-Analysis | 1 2 3 4 5 6 7 8 9 10 The concept of metabolic syndrome was first introduced in 1988 as “Syndrome X” to describe the frequent clustering of insulin resistance with metabolic abnormalities that increase the risk of type 2 diabetes mellitus and cardiovascular disease [,]. | 3 | Starvaggi Josè (2026) | Selected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications |
| Berberine Insulin Resistance Meta-Analysis | This definition identifies metabolic syndrome based on the presence of at least three of the following components: increased waist circumference (population specific), hypertriglyceridemia and/or reduced HDL cholesterol, elevated blood pressure, and impaired fasting glucose [,]. | 3 | Starvaggi Josè (2026) | Selected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications |
| Berberine Insulin Resistance Meta-Analysis | 15 16 17 14 18 Accumulating evidence indicates that fat distribution rather than total adiposity is the principal determinant of metabolic risk. | 3 | Starvaggi Josè (2026) | Selected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications |
| Berberine Insulin Resistance Meta-Analysis | The term was later refined to “metabolic syndrome” to avoid confusion with cardiac Syndrome X and to better reflect the underlying metabolic dysregulation []. | 3 | Starvaggi Josè (2026) | Selected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications |
Source documents